Rhumbline Advisers Rvl Pharmaceuticals PLC Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.8 - $3.78 $45,948 - $62,029	-16,410 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$3.26 - $4.84 $2,852 - $4,235	875 Added 5.63%	16,410 $53,000
Q4 2020 Feb 10, 2021	BUY	$4.12 - $6.29 $5,912 - $9,026	1,435 Added 10.18%	15,535 $64,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $8.77 $10,367 - $18,864	-2,151 Reduced 13.24%	14,100 $76,000
Q2 2020 Aug 13, 2020	BUY	$2.83 - $6.99 $9,033 - $22,312	3,192 Added 24.44%	16,251 $109,000
Q4 2019 Feb 05, 2020	BUY	$3.46 - $7.7 $692 - $1,540	200 Added 1.56%	13,059 $91,000
Q3 2019 Oct 23, 2019	BUY	$2.8 - $3.99 $2,749 - $3,918	982 Added 8.27%	12,859 $49,000
Q2 2019 Aug 14, 2019	BUY	$2.34 - $4.28 $27,792 - $50,833	11,877 New	11,877 $45,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.